Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
1996-10-22
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, A61K 3152
Patent
active
055677045
ABSTRACT:
There is disclosed compounds and pharmaceutical compositions that are a resolved R or S (preferably R) enantiomer of an .omega.-1 alcohol of a straight chain alkyl (C.sub.5-8) substituted at the 1-position of 3,7-disubstituted xanthine. The inventive compounds are effective in treating baldness.
REFERENCES:
patent: 3373433 (1968-03-01), Mohler et al.
patent: 3422107 (1969-01-01), Mohler et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4525309 (1985-06-01), Matteson et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5112827 (1992-05-01), Saunders et al.
patent: 5118500 (1992-06-01), H anel et al.
patent: 5272153 (1993-12-01), Mandell et al.
patent: 5310666 (1994-05-01), Aretz et al.
patent: 5409935 (1995-04-01), Schubert et al.
Bianco et al., Blood, vol. 78, No. 5, pp. 1205-1211, "Phase I-II Trial of Pentoxifylline for the Prevention of Transplant-Related Toxicities Following Bone Marrow Transplantation", 1991.
Davis et al., Applied And Environmental Microbiology, vol. 48, No. 2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", 1984.
Davis et al., Xenobiotica, vol. 15, No. 12, pp. 1001-1010, "Microbial Models of Mammalian Metabolism: Stereospecificity of Ketone Reduction with Pentoxifylline", 1985.
Matteson et al., J. Am. Chem. Soc., vol. 108, pp. 810-819, "99% Chirally Selective Syntheses via Pinanediol Boronic Esters: Insect Pheromones, Diols, and an Amino Alcohol", 1986.
Soundarajan et al., J. Org. Chem., vol. 55, pp. 2274-2275, "Hydroboration with Boron Halides and Trialkylsilanes", 1990.
Bianco James A.
Porubek David
Singer Jack
Woodson Paul
Cell Therapeutics Inc.
Criares Theodore J.
Oster Jeffrey B.
LandOfFree
R-enatiomerically pure hydroxylated xanthine compounds to treat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with R-enatiomerically pure hydroxylated xanthine compounds to treat , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R-enatiomerically pure hydroxylated xanthine compounds to treat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358823